New research indicates that patients who discontinue new GLP-1 drugs like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who stop traditional lifestyle regimens.
Published data in a prominent medical journal points out that while obese individuals frequently drop substantial amounts of their total mass while using the jabs, the weight is regained at an average rate of 0.8 kg per month upon discontinuation.
"Individuals purchasing these medications need to be cognizant of the danger of quick rebound weight gain when the treatment is stopped," stated expert Dr. Susan Jebb.
This pace of regain suggests a reversion to pre-treatment mass in about one and a half years.
Comparing Approaches
The analysis, which looked at dozens of trials involving thousands of patients, contrasted the effects of GLP-1 agonists with other pills.
Researchers emphasize that people who shed pounds through lifestyle changes alone generally experience a slower creep back—perhaps 0.1 kg a month—post-intervention.
The Reason for the Fast Regain
Doctors propose the mechanism of the jabs explains the accelerated rebound.
The injections mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 levels far above than normal could lead to the body to produce less of its endogenous hormone, and may also diminish responsiveness to its actions," explained Dr. Adam Collins, a dietetics expert.
"Discontinuation of this hormone supplement results in hunger is no longer kept in check, making overeating far more likely."
A Chronic Condition?
Medical guidelines advise the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Many experts argue that, due to the likelihood of relapse, the treatment might need to be life-long.
This perspective is supported by drug manufacturers, who say that the results "emphasize the chronic character of excess weight," similar to managing diseases like diabetes.
User Accounts
Users who have come off the jabs describe a powerful resurgence of hunger.
"I experienced a trigger that goes on and you're instantly extremely hungry," said a patient.
This challenge is compounded if users have not adopted sustainable lifestyle or habit changes during therapy.
Widespread Interest
Recent estimates indicate that a significant number of people in the UK have tried these injections in the past year, with interest being substantial.
- Use is more common among females than men.
- The 40s and 50s demographic shows the highest usage rates.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, researchers caution that while these medications are effective tools for weight loss, they are not a standalone cure and maintained weight loss likely depends on ongoing behavioural support.
